– Acquisition to open up ANZ as a new client market - Addition of 1,100+ domain experts and four delivery centers…
Study demonstrates reduction of a-synuclein aggregation and preservation of neurons MELBOURNE, Australia, Jan. 28, 2022 /PRNewswire/ – Alterity Therapeutics (ASX: ATH,…
Lonza to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art…
Highlights: NZ’s regulator Medsafe authorizes Phase 2 clinical trial for ATH434; more jurisdictions to follow New poster presentation and publications…
MELBOURNE, Australia, Jan. 26, 2022 /PRNewswire/ — CRRC Corporation Limited ("CRRC", 1766.HK) announced that four additional second-generation SDA1 Locomotives have shipped…
Leading multichannel commerce platform now offers over 300 global marketplace and retailer integrations MELBOURNE, Australia, Jan. 26, 2022 /PRNewswire/ — ChannelAdvisor Corporation…
SYDNEY, Jan. 25, 2022 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased…
>> ECINS Australia Offers Collaborative Case Management Software to Empower Indigenous Organisations & Educational Institutions to Streamline Processes in Order…
MELBOURNE, Australia, Jan. 21, 2022 /PRNewswire/ – Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers…
MELBOURNE, Australia, Jan. 20, 2022 /PRNewswire/ – Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers…
